Effect of phentolamine and preperfusion with glucose on insulin release from the isolated perfused pancreas from fasted and fed rats
- 1 October 1975
- journal article
- Published by Springer Nature in Diabetologia
- Vol. 11 (5) , 407-410
- https://doi.org/10.1007/bf00429908
Abstract
Starvation of rats for 24 hrs resulted in decreased insulin release from the isolated rat pancreas. The effect of fasting could not be counteracted by elevation of the glucose level in the equilibration medium from 0.8 to 1.5 mg/ml. The alpha-adrenergic blocking agent phentolamine (10 μg/ml) stimulated glucose induced insulin release to approximately the same extent in fasted as in fed rats. These findings illustrate the importance of endogenous catecholamines in the regulation of insulin secretion from the isolated pancreas. Our experiments suggest that the impairment of insulin secretion on fasting is due neither to the inhibitory effect of catecholamines nor to the lack of substrate in the pancreas at the initiation of the stimulation.Keywords
This publication has 14 references indexed in Scilit:
- Glucose-induced insulin release patterns: Effect of starvationDiabetologia, 1974
- Release of large amounts of noradrenaline from the isolated perfused canine pancreas during glucose deprivationDiabetologia, 1973
- Effects of feeding and fasting on the insulin secretory response to glucose and sulfonylureas in intact rats and isolated perfused rat pancreasDiabetologia, 1973
- Role of Pancreatic Monoamines in the Impaired Insulin Secretion of the Fasting StateEndocrinology, 1973
- Interaction of Various Stimulators and Inhibitors on Insulin Secretion in vitroHormone Research, 1973
- Adrenergic Modulation of Basal Insulin Secretion in ManDiabetes, 1973
- ANTAGONISM BETWEEN GLUCOSE AND EPINEPHRINE REGARDING INSULIN SECRETIONActa Medica Scandinavica, 1971
- The effect of fasting, diet, and actinomycin D on insulin secretion in the ratJournal of Clinical Investigation, 1970
- Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamideDiabetologia, 1969
- A Receptor Mechanism for the Inhibition Of Insulin Release by Epinephrine in Man*Journal of Clinical Investigation, 1967